EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

When Nature Meets Oncology: Unraveling Herb–Drug Interactions in Cancer Therapy

Ayush Gandhi iD, Samip Master, Viraj Bhise

International Journal of Molecular Sciences · 29.10.2025 · 26 (21) · 10494

DOI: 10.3390/ijms262110494 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.10.2025. Verfasst von Ayush Gandhi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Neoplasms, Herb-Drug Interactions, Antineoplastic Agents, Biological Products. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural product (NP) use by patients alongside their conventional cancer therapies is ubiquitous. This common, yet often hidden, practice can potentially contribute to significant patient harm, given the narrow therapeutic window of most anticancer drugs. This review takes on this challenge directly, moving past theoretical concerns to summarize current clinical evidence on interactions between widely used NPs and modern cancer treatments, including chemotherapy, targeted therapy, and immunotherapy. We break down the key pharmacokinetic (PK) mechanisms, such as the disruption of cytochrome P450 enzymes, and the pharmacodynamic (PD) effects that can either help or hinder treatment. By examining both well-established clinical interactions and those supported by preliminary or preclinical findings, we highlight how NPs may alter the effectiveness of anticancer medications and where evidence remains uncertain. Lack of reliable safety information for NPs along with widespread use of these products by patient populations has the potential to impact clinical care and patient outcomes significantly, frequently causing harm. We advocate for improved patient-provider communication and additional evidence-based research to address this gap in literature. The majority of reported interactions are based on preclinical or limited clinical evidence. A more rigorous evidence base including real-world data and clinical trials is urgently needed to guide practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHerb-Drug InteractionsAntineoplastic AgentsBiological ProductsHumansAnimalsCytochrome P-450 Enzyme System

Stichwörter der Autor:innen

cancerchemotherapycytochrome P450herb-drug interactionsimmunotherapynatural productstargeted therapy

Substanzen

Antineoplastic AgentsBiological ProductsCytochrome P-450 Enzyme System

Autor:innen und Institutionen

  • Department of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Texas Oncology, Webster, TX 77598, USA.

ORCID-Profile: Ayush Gandhi

Zitieren

APA

Gandhi, A., Master, S., & Bhise, V. (2025). When Nature Meets Oncology: Unraveling Herb–Drug Interactions in Cancer Therapy. International Journal of Molecular Sciences, 26(21), 10494. https://doi.org/10.3390/ijms262110494

Vancouver

Gandhi A, Master S, Bhise V. When Nature Meets Oncology: Unraveling Herb–Drug Interactions in Cancer Therapy. International Journal of Molecular Sciences. 2025;26(21):10494. doi:10.3390/ijms262110494

BibTeX
@article{Gandhi2025,
  author = {Gandhi, Ayush and Master, Samip and Bhise, Viraj},
  title = {When Nature Meets Oncology: Unraveling Herb–Drug Interactions in Cancer Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {21},
  pages = {10494},
  doi = {10.3390/ijms262110494}
}
Kostenlos starten →